PharVision Advisers’s Seagate STX Stock Holding History

PharVision Advisers’s Portfolio STX Stock Details STX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,648	Closed	-$454K	–	575
2025 Q4	$454K	Buy	+1,648	New	+$428K	0.23%	68
2025 Q3	–	Sell	-1,633	Closed	-$236K	–	791
2025 Q2	$236K	Buy	+1,633	New	+$169K	0.34%	156

Other funds holding STX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PharVision Advisers's STX Position: Q1 2026 in Review

PharVision Advisers sold out of Seagate (STX) in Q1 2026, closing a stake of 1,648 shares — an estimated $454K sold.

PharVision Advisers first reported a position in STX in Q2 2025 and held it in 2 quarters. The position peaked at $454K in Q4 2025. 1,455 funds tracked by Wall St. Rank hold STX as of Q1 2026.

PharVision Advisers reported no remaining Seagate position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 1,648 Seagate shares in Q1 2026, an estimated $454K.
PharVision Advisers first reported a position in Seagate in Q2 2025 and held it in 2 quarters.
PharVision Advisers's Seagate position peaked at $454K in Q4 2025.
1,455 funds tracked by Wall St. Rank held Seagate as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.